Related Experiment Video

Updated: May 9, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

The role of human complement factor H in retinal immune response and the prospects for targeted therapy for

Anne Wolf1,2, Thomas Clahsen2,3, Thomas Langmann1

  • 1Laboratory for Experimental Immunology of the Eye, Department of Ophthalmology, University of Cologne, Cologne, Germany.

Expert Opinion on Therapeutic Targets
|May 8, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
AMDCFH; Microgliaalternative pathwaycomplement system

More Related Videos

Enrichment of Bruch's Membrane from Human Donor Eyes
10:22

Enrichment of Bruch's Membrane from Human Donor Eyes

Published on: November 15, 2015

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
06:48

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

Related Experiment Videos

Last Updated: May 9, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

Enrichment of Bruch's Membrane from Human Donor Eyes
10:22

Enrichment of Bruch's Membrane from Human Donor Eyes

Published on: November 15, 2015

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
06:48

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

Related Concept Videos

iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Articles linked to this work by shared authors, journal, and citation graph.

Sialylation as a checkpoint for inflammatory and complement-related retinal diseases.

Frontiers in cellular neuroscience·2025

Immunomodulation of inflammatory responses preserves retinal integrity in murine models of pericyte-depletion retinopathy.

JCI insight·2025

Moss-derived human complement factor H modulates retinal immune response and attenuates retinal degeneration.

Journal of neuroinflammation·2025

Severe Joubert syndrome in family with homozygous POC1B p.Arg106Pro variant is due to a co-inherited deep-intronic mutation in the neighboring CEP290 gene.

HGG advances·2025

Inhibition of DYRK1B BY C81 impedes inflammatory processes in leukocytes by reducing STAT3 activity.

Cellular and molecular life sciences : CMLS·2025

Kinetic changes in microglia-related retinal transcripts in experimental autoimmune uveoretinitis (EAU) of B10.RIII mice.

Journal of neuroinflammation·2025

Targeting the microbiota-gut-brain axis in Alzheimer's and Parkinson´s disease: recent therapeutic approaches.

Expert opinion on therapeutic targets·2026

Molecular basis for developing tumor-targeted siRNAs for future immunotherapy.

Expert opinion on therapeutic targets·2026

Overcoming adaptive resistance to cancer immunotherapy: molecular targeting strategies for the tumor microenvironment.

Expert opinion on therapeutic targets·2026

Targeting protein misfolding and aggregation in neurodegenerative diseases: challenges for the identification and validation of targets for small molecules.

Expert opinion on therapeutic targets·2026

New and emerging therapeutics and molecular targets for attention-deficit hyperactivity disorder.

Expert opinion on therapeutic targets·2026

VAV1 targeting for cancer therapeutics: mechanistic understanding and preclinical promise.

Expert opinion on therapeutic targets·2026

Platelets in sickle cell disease: biomarkers, mediators, and lessons from clinical trials.

Blood vessels, thrombosis & hemostasis·2026

[Atypical hemolytic uremic syndrome following a late miscarriage: a case report].

Harefuah·2026

Development of a Rapid RPA-CRISPR/Cas12b Assay for Dual Detection of Hantaan Virus and Seoul Virus.

Journal of virological methods·2026

ThaCoder: an explainable deep learning framework for thalassemia screening using routine complete blood count: a multi-center validation study.

Clinica chimica acta; international journal of clinical chemistry·2026

Efficient Generation of Definitive-like Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells through Optimized Lateral Plate Mesoderm Induction and a Supportive Endothelial-Stromal Microenvironment.

Acta biomaterialia·2026

Haginin A suppresses oxidative stress and pro-inflammatory mediators via MAPK and inflammasome regulation in LPS-stimulated microglia.

Journal of neuroimmunology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us